Ingemar Turesson
1 – 10 of 98
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=""
width=""
height=""
allowtransparency="true"
frameborder="0">
</iframe>
- 2018
- Outcome and survival of myeloma patients diagnosed 2008-2015. Real-world data on 4904 patients from the Swedish Myeloma Registry
- The multiple myeloma risk allele at 5q15 lowers ELL2 expression and increases ribosomal gene expression
- 2017
- Natural history of relapsed myeloma, refractory to immunomodulatory drugs and proteasome inhibitors : a multicenter IMWG study
- Incidence, characteristics, and outcome of solitary plasmacytoma and plasma cell leukemia. Population-based data from the Swedish Myeloma Register
- Direct evidence for a polygenic etiology in familial multiple myeloma
- 2016
- Management of relapsed multiple myeloma: Recommendations of the international myeloma working group.
- Incidence of multiple myeloma in Great Britain, Sweden, and Malmö, Sweden: the impact of differences in case ascertainment on observed incidence trends.
- Survival in multiple myeloma patients who develop second malignancies: a population-based cohort study.
- Genome-wide association study identifies multiple susceptibility loci for multiple myeloma
- 2015
- Variants in ELL2 influencing immunoglobulin levels associate with multiple myeloma.